EDGAR Filing Documents for 0001193125-15-410872

Form 8-K - Current report:

SEC Accession No. 0001193125-15-410872

Filing Date

2015-12-22

Accepted

2015-12-22 16:37:35

Documents

Period of Report

2015-12-22

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 8-K	d110445d8k.htm	8-K	25719
2	EX-4.1	d110445dex41.htm	EX-4.1	917353
3	EX-10.1	d110445dex101.htm	EX-10.1	223112
4	EX-99.1	d110445dex991.htm	EX-99.1	9054
5	GRAPHIC	g110445ex99_1logo.jpg	GRAPHIC	5524
	Complete submission text file	0001193125-15-410872.txt		1184370

Mailing Address ONE KENDALL SQUARE SUITE B7201 CAMBRIDGE MA 02139

Business Address ONE KENDALL SQUARE SUITE B7201 CAMBRIDGE MA 02139 617-441-1000

MERRIMACK PHARMACEUTICALS INC (Filer) CIK: 0001274792 (see all company filings)